Protein profile

PA5221

2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase

Genome: NC_002516.2

Gene: PA5221 Structure source: AlphaFold UniProt Q9HTW9
Amino acids 405
Annotations 7
Features 24
PDB binders 4
Druggability 0.935

Overview

Basic information about this protein and its source genome.

Accession
PA5221
Gene
PA5221
Status
annotated
Amino acids
405
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
33.152
Human E-value
1.5400000000000001e-22
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
CytoplasmicMembrane

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.935
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

7 GO

Gene Ontology (GO)

7
  • GO:0110142 A protein complex composed of enzymes and accessory factors of the ubiquinone (CoQ) biosynthesis pathway. In E. coli, the complex is composed of seven proteins: UbiE, F, G, H, I, J and K. In eukaryotes, the complex is located on the matrix face of the inner mitochondrial membrane and includes COQ3, COQ4, COQ5, COQ6, COQ7, COQ9.
  • GO:0019168 Catalysis of the reaction: a 2-(all-trans-polyprenyl)phenol + NADPH + O2 + H+ = a 3-(all-trans-polyprenyl)benzene-1,2-diol + NADP+ + H2O.
  • GO:0071949 Binding to the oxidized form, FAD, of flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
  • GO:0006744 The chemical reactions and pathways resulting in the formation of ubiquinone, a lipid-soluble electron-transporting coenzyme.
  • GO:0016709 Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from NADH or NADPH and one other donor, and one atom of oxygen is incorporated into one donor.
  • GO:0016705 Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from each of two donors, and molecular oxygen is reduced or incorporated into a donor.
  • GO:0050660 Binding to FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.

Sequence Features

Domain/signature hits from InterPro and related databases.

24 records
Show feature table
Start End DB Term Name
21 405 Phobius NON_CYTOPLASMIC_DOMAIN Region of a membrane-bound protein predicted to be outside the membrane, in the extracellular region.
2 394 PANTHER PTHR43876 UBIQUINONE BIOSYNTHESIS MONOOXYGENASE COQ6, MITOCHONDRIAL
4 346 Pfam PF01494 FAD binding domain
4 346 InterPro IPR002938 FAD-binding domain
4 394 NCBIfam TIGR01988 ubiquinone biosynthesis hydroxylase, UbiH/UbiF/VisC/COQ6 family
4 394 InterPro IPR010971 Ubiquinone biosynthesis hydroxylase UbiH/COQ6
264 394 FunFam G3DSA:3.50.50.60:FF:000021 Ubiquinone biosynthesis monooxygenase COQ6
267 405 Gene3D G3DSA:3.50.50.60 -
267 405 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
1 221 Gene3D G3DSA:3.50.50.60 -
1 221 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
1 18 SignalP_EUK SignalP-noTM SignalP-noTM
1 400 SUPERFAMILY SSF51905 FAD/NAD(P)-binding domain
1 400 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
5 13 Phobius SIGNAL_PEPTIDE_H_REGION Hydrophobic region of a signal peptide.
1 4 Phobius SIGNAL_PEPTIDE_N_REGION N-terminal region of a signal peptide.
298 311 ProSitePatterns PS01304 ubiH/COQ6 monooxygenase family signature.
298 311 InterPro IPR018168 Ubiquinone biosynthesis hydroxylase, UbiH/UbiF/VisC/COQ6, conserved site
1 20 Phobius SIGNAL_PEPTIDE Signal peptide region
14 20 Phobius SIGNAL_PEPTIDE_C_REGION C-terminal region of a signal peptide.
284 299 PRINTS PR00420 Aromatic-ring hydroxylase (flavoprotein monooxygenase) signature
156 171 PRINTS PR00420 Aromatic-ring hydroxylase (flavoprotein monooxygenase) signature
4 26 PRINTS PR00420 Aromatic-ring hydroxylase (flavoprotein monooxygenase) signature
299 315 PRINTS PR00420 Aromatic-ring hydroxylase (flavoprotein monooxygenase) signature

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA5221
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
3 0.935
9 0.294

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

58 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
61M Q9HWJ1 179.2 Da LogP 0.93 TPSA 80.4 ✓ Ro5 ✓ Clean c1ccc(c(c1)C(=O)CC(=O)O)N
7ZR P38169 421.5 Da LogP 3.54 TPSA 120.7 ✓ Ro5 Alert COc1ccc(cc1OC)S(=O)(=O)Nc2nc(cs2)c3cccc(c3)[N+]…
PM0 Q194P4 1093.1 Da LogP 0.79 TPSA 355.0 3 viol. ✓ Clean Cc1c(cc2cc3c(c(c2c1O)O)C(=O)[C@]4([C@@H](C3)[C@…
RFP F2R776 823.0 Da LogP 4.34 TPSA 220.1 3 viol. Alert Cc1c(c2c3c4c1O[C@@](C4=O)(O\C=C\[C@@H]([C@H]([C…

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.